David Ricks — CEO, Eli Lilly

**David Alexander Ricks** is the Chairman and CEO of Eli Lilly and Company, which has become the world's most valuable pharmaceutical company on the back of its GLP-1 blockbusters — Mounjaro (tirzepatide for diabetes) and Zepbound (tirzepatide for obesity). Annual revenue is Need to verify against most recent quarterly/annual earnings and surging, with a This metric changes daily and needs current calculation, making Lilly one of the best-performing large-cap stocks in the market. Born in the United States, he earned a BS from Purdue University and an MBA from Indiana University's Kelley School of Business.